著書論文等- 藤原 亨 -
表示方法: 表示形式: 表示順:
[]:著書 []:論文 []:総説・解説記事
件数:184件
[2019]
1.[] Flow Cytometry-Based Photodynamic Diagnosis with 5-Aminolevulinic Acid for the Detection of Minimal Residual Disease in Multiple Myeloma..[The Tohoku journal of experimental medicine,249(1),(2019),19-28]Iwaki K, Fujiwara T, Ito T, Suzuki C, Sasaki K, Ono K, Saito K, Fukuhara N, Onishi Y, Yokoyama H, Fujimaki S, Tanaka T, Tamura H, Fujiwara M, Harigae H
10.1620/tjem.249.19
http://www.ncbi.nlm.nih.gov/pubmed/31511451
2.[] Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma..[Annals of hematology,98(8),(2019),1999-2001]Ryo Nakagawa, Yasushi Onishi, Akihisa Kawajiri, Koichi Onodera, Eijiro Furukawa, Sayaka Sano, Kei Saito, Satoshi Ichikawa, Tohru Fujiwara, Noriko Fukuhara, Hideo Harigae
10.1007/s00277-019-03645-7
http://www.ncbi.nlm.nih.gov/pubmed/30824957
3.[] microBCR-ABL1を認めた慢性骨髄性白血病の1例.[日本検査血液学会雑誌,20(学術集会), (2019), S214]鈴木 千恵, 菅原 新吾, 佐藤 亜耶, 安 久美子, 平泉 敦子, 藤巻 慎一, 賀来 満夫, 市川 聡, 藤原 亨, 張替 秀郎
4.[] 免疫不全に合併したNTM症 MonoMAC症候群.[結核,94(3), (2019), 168]福原 規子, 藤原 亨, 張替 秀郎
5.[] Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia..[Free Radic Biol Med.,133,(2019),179-185]Fujiwara T, Harigae H.
6.[] Umbilical Cord Blood Transplantation Using Reduced-intensity Conditioning without Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia..[Biol Blood Marrow Transplant.,25,(2019),e55-e59]Ochi T, Onishi Y, Nasu K, Onodera K, Kobayashi M, Ichikawa S, Fujiwara T, Fukuhara N, Yamada-Fujiwara M, Harigae H
7.[] Sideroblastic anemia – deepening of genomic medicine and future prospects..[Rinsho Ketsueki.,60,(2019),408-416]Fujiwara T
8.[] Generation and molecular characterization of human ring sideroblasts: A key role of ferrous iron in erythroid differentiation and ring sideroblast formation..[Mol Cell Biol.,(2019)]Saito K, Fujiwara T, Hatta S, Morita M, Ono K, Suzuki C, Fukuhara N, Onishi Y, Nakamura Y, Kawamata S, Shimizu R, Yamamoto M, Harigae H.
9.[] Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach..[Int J Hematol.,(2019)]Kedar PS, Harigae H, Ito E, Muramatsu H, Kojima S, Okuno Y, Fujiwara T, Dongerdiye R, Warang PP, Madkaikar MR.
[2018]
10.[] Infection perturbs Bach2- and Bach1-dependent erythroid lineage 'choice' to cause anemia..[Nature immunology,19(10),(2018),1059-1070]Hiroki Kato, Ari Itoh-Nakadai, Mitsuyo Matsumoto, Yusho Ishii, Miki Watanabe-Matsui, Masatoshi Ikeda, Risa Ebina-Shibuya, Yuki Sato, Masahiro Kobayashi, Hironari Nishizawa, Katsushi Suzuki, Akihiko Muto, Tohru Fujiwara, Yasuhito Nannya, Luca Malcovati, Mario Cazzola, Seishi Ogawa, Hideo Harigae, Kazuhiko Igarashi
10.1038/s41590-018-0202-3
http://www.ncbi.nlm.nih.gov/pubmed/30250186
11.[] 血液フロンティア;赤血球分化の転写制御(医薬ジャーナル社).[(2018), 17-22]藤原 亨
12.[] X連鎖性鉄芽球性貧血の細胞モデルの解析(Characterization of in vitro model of X-linked sideroblastic anemia).[臨床血液,59(9), (2018), 1498]齋藤 慧, 藤原 亨, 八田 俊介, 小野寺 晃一, 市川 聡, 福原 規子, 大西 康, 中村 幸夫, 張替 秀郎
13.[] 転写因子GATA-2の制御因子同定のためのスクリーニング法の確立(Establishment of a screening system to identify novel GATA-2 transcriptional regulators).[臨床血液,59(9), (2018), 1696]大橋 圭一, 藤原 亨, 小野寺 晃一, 齋藤 陽, 市川 聡, 小林 匡洋, 沖津 庸子, 福原 規子, 大西 康, 張替 秀郎
14.[] T-LGL白血病に対するシクロスポリンA治療 単施設の経験(Cyclosporine A treatment for T-cell large granular lymphocytic leukemia: a single-center experience).[臨床血液,59(9), (2018), 1569]大西 康, 藤原 実名美, 佐野 沙矢香, 中川 諒, 川尻 昭寿, 齋藤 慧, 小野寺 晃一, 市川 聡, 福原 規子, 藤原 亨, 張替 秀郎
15.[] short tandem repeat(STR)-PCR法を用いた造血幹細胞移植後のキメリズム解析の評価.[日本検査血液学会雑誌,19(学術集会), (2018), S163]関 修, 成田 香魚子, 大西 康, 福原 規子, 藤原 亨, 藤原 実名美, 張替 秀郎
16.[] Establishment of a Screening System to Identify Novel GATA-2 Transcriptional Regulators..[The Tohoku journal of experimental medicine,244(1),(2018),41-52]Keiichi Ohashi, Tohru Fujiwara, Koichi Onodera, Yo Saito, Satoshi Ichikawa, Masahiro Kobayashi, Yoko Okitsu, Noriko Fukuhara, Yasushi Onishi, Hideo Harigae
10.1620/tjem.244.41
http://www.ncbi.nlm.nih.gov/pubmed/29343653
17.[] A defined culture method enabling the establishment of ring sideroblasts from induced pluripotent cells of X-linked sideroblastic anemia..[Haematologica.,103,(2018),e188-e191]Hatta S, Fujiwara T, Yamamoto T, Saito K, Kamata M, Tamai Y, Kawamata S, Harigae H.
18.[] Successful treatment with vitamin B6 for X-linked sideroblastic anemia with ALAS2 R452H mutation..[Rinsho Ketsueki.,59,(2018),401-406]Kawakami T, Nakazawa H, Kawakami F, Matsuzawa S, Sudo Y, Sakai H, Nishina S, Sendo N, Sendo Y, Komatsu M, Umemura T, Yamaguti T, Kosho T, Fujiwara T, Harigae H, Ishida F.
19.[] Five-aminolevulinic acid: New Approach for Congenital Sideroblastic Anemia..[Pediatr Int.,60,(2018),496-497]Ishida H, Imamura T, Morimoto A, Fujiwara T, Harigae H.
20.[] Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia..[Free Radic Biol Med.,(2018)]Fujiwara T, Harigae H
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [next]
戻るこのページのトップへ
copyright(c)2005 Tohoku University